Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
更正：SARS-CoV-2疫苗在中国肝硬化患者中的安全性和免疫原性：一项前瞻性多中心研究
期刊:Hepatology International
影响因子:6.1
doi:10.1007/s12072-023-10598-7
Wang, Jitao; Zhang, Qiran; Ai, Jingwen; Liu, Dengxiang; Liu, Chuan; Xiang, Huiling; Gu, Ye; Guo, Ying; Lv, Jiaojian; Huang, Yifei; Liu, Yanna; Xu, Dan; Chen, Shubo; Li, Jinlong; Li, Qianqian; Liang, Jing; Bian, Li; Zhang, Zhen; Guo, Xiaoqing; Feng, Yinong; Liu, Luxiang; Zhang, Xuying; Zhang, Yanliang; Xie, Faren; Jiang, Shujun; Qin, Wei; Wang, Xiaodong; Rao, Wei; Zhang, Qun; Tian, Qiuju; Zhu, Ying; Cong, Qingwei; Xu, Juan; Hou, Zhiyun; Zhang, Nina; Zhang, Aiguo; Zu, Hongmei; Wang, Yun; Yan, Zhaolan; Du, Xiufang; Hou, Aifang; Yan, Yan; Qiu, Yuanwang; Wu, Hangyuan; Hu, Shengjuan; Deng, Yanhong; Ji, Jiansong; Yang, Jie; Huang, Jiansheng; Zhao, Zhongwei; Zou, Shengqiang; Ji, Hailei; Ge, Guohong; Zhong, Li; He, Song; Yan, Xiaosong; Yangzhen, Bian Ba; Qu, Ci; Zhang, Liting; Yang, Shiying; Gao, Xiaoqin; Lv, Muhan; Zhu, Qingliang; Xu, Xinxin; Zeng, Qing-Lei; Qi, Xiaolong; Zhang, Wenhong
